Document Type : Original Article


Department of Virology, Faculty of Veterinary Medicine, Mehmet Akif Ersoy University, Burdur, Türkiye


Canine parvovirus type 2 (CPV-2) causes hemorrhagic enteritis, and is one of the most important and contagious pathogens of dogs. In this study, we aimed to determine the prevalence and antigenic variants of CPV enteritis in dogs. Fecal samples were collected from 35 dogs with mucoid to hemorrhagic diarrhea in the Western Mediterranean region of Türkiye between October 2019 and March 2021. DNA was isolated from the samples and examined using PCR analysis. Twenty-eight out of 35 dogs (80.00%) were detected to be positive for CPV. Of these, three had already been vaccinated. The partial VP2 genes of 15 CPV positive samples producing strong bands in agarose gels were sequenced. All strains were identified as CPV-2b, and the amino acid changes were identified. Discriminative amino acid changes were detected for different amino acid positions clearly defining new CPV-2b variants. Of the 15 isolates, three had previously unreported synonymous mutations. Phylogenetic analysis indicated that the strains obtained in this study were closely related to isolates from the Mersin province of Türkiye, except for three isolates that had synonymous mutations and were located in a separate branch from the other CPV-2b genetic variants previously detected in Mersin Province and Urfa Province in Türkiye. This study demonstrates the increase in the prevalence rates for CPV-2b circulating in vaccinated and nonvaccinated dogs. Taking into account the data from phylogenetic trees which highlights differences between the vaccine strains and the isolates, re-designing immunization strategies needs necessary.


  1. Gargari S. The detection and molecular characterization of canine parvovirus type-2 in dogs with gastroenteritis symptoms [Turkish]. PhD Thesis. Ankara University Health Sciences Institution. Ankara, Turkey: 2015.
  2. Khatri R, Poonam, Mohan H, et al. Epidemiology, pathogenesis, diagnosis and treatment of canine parvovirus disease in dogs: a mini review. J Vet Sci Med Diagn 2017; 6: 3. doi: 10.4172/2325-9590.1000233.
  3. Nandi S, Sharma GK, Gupta V, et al. Global scenario of canine parvovirus mutants: epidemiology, diagnostics and immunoprophylactic agents. JSM Vet Med Res 2019; 2: 12.
  4. Dei Giudici S, Cubeddu T, Giagu A, et al. First molecular characterization of canine parvovirus strains in Sardinia, Italy. Arch Virol 2017; 162(11): 3481-3486.
  5. Reed AP, Jones EV, Miller TJ. Nucleotide sequence and genome organization of canine parvovirus. J Virol 1988; 62(1): 266-276.
  6. Gupta SK, Sahoo AP, Rosh N, et al. Canine parvovirus NS1 induced apoptosis involves mitochondria, accumulation of reactive oxygen species and activation of caspases. Virus Res 2016; 213: 46-61.
  7. Simpson AA, Chandrasekar V, Hébert B, et al. Host range and variability of calcium binding by surface loops in the capsids of canine and feline parvoviruses. J Mol Biol 2000; 300(3): 597-610.
  8. Decaro N, Buonavoglia C. Canine parvovirus--a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155(1): 1-12.
  9. Appel MJ, Scott FW, Carmichael LE. Isolation and immunization studies of a canine parco-like virus from dogs with haemorrhagic enteritis. Vet Rec 1979; 105(8): 156-159.
  10. Decaro N, Elia G, Desario C, et al. A minor groove binder probe real-time PCR assay for discrimination between type 2-based vaccines and field strains of canine parvovirus. J Virol Methods 2006; 136(1-2): 65-70.
  11. Takano T, Hamaguchi S, Hasegawa N, et al. Predominance of canine parvovirus 2b in Japan: an epidemiological study during 2014-2019. Arch Virol 2021; 166(11): 3151-3156.
  12. Nguyen Manh T, Piewbang C, Rungsipipat A, et al. Molecular and phylogenetic analysis of Vietnamese canine parvovirus 2c originated from dogs reveals a new Asia-IV clade. Transbound Emerg Dis 2021; 68(3): 1445-1453.
  13. Ahmed N, Riaz A, Zubair Z, et al. Molecular analysis of partial VP-2 gene amplified from rectal swab samples of diarrheic dogs in Pakistan confirms the circulation of canine parvovirus genetic variant CPV-2a and detects sequences of feline panleukopenia virus (FPV). Virol J 2018; 15(1): 45. doi: 10.1186/s12985-018-0958-y.
  14. Duque-García Y, Echeverri-Zuluaga M, Trejos-Suarez J, et al. Prevalence and molecular epidemiology of Canine parvovirus 2 in diarrheic dogs in Colombia, South America: A possible new CPV- 2a is emerging? Vet Microbiol 2017; 201: 56-61.
  15. Hao X, He Y, Wang C, et al. The increasing prevalence of CPV-2c in domestic dogs in China. PeerJ 2020; 8: e9869. doi: 10.7717/peerj.9869.
  16. Buonavoglia C, Martella V, Pratelli A, et al. Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol 2001; 82(Pt 12): 3021-3025.
  17. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22(22): 4673-4680.
  18. Rossi RJ. Mathematical statistics: an introduction to likelihood based inference. John New York, USA: Wiley & Sons 2018; 223-239.
  19. Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol 2021; 38(7): 3022-3027.
  20. Moon HS, Lee SA, Lee SG, et al. Comparison of the pathogenicity in three different Korean canine parvovirus 2 (CPV-2) isolates. Vet Microbiol 2008; 131(1-2): 47-56.
  21. Timurkan M, Oğuzoğlu T. Molecular characterization of canine parvovirus (CPV) infection in dogs in Turkey. Vet Ital 2015; 51(1): 39-44.
  22. Yeşilbağ K, Yilmaz Z, Ozkul A, et al. Aetiological role of viruses in puppies with diarrhea. Vet Rec 2007; 161(5): 169-170.
  23. Yilmaz Z, Pratelli A, Torun S. Distribution of antigen types of canine parvovirus type 2 in dogs with hemorrhagic enteritis in Turkey. Turk J Vet Anim Sci 2005; 29: 1073-1076.
  24. Battilani M, Modugno F, Mira F, et al. Molecular epidemiology of canine parvovirus type 2 in Italy from 1994 to 2017: recurrence of the CPV-2b variant. BMC Vet Res 2019; 15(1): 393. doi: 10.1186/s12917-019-2096-1.
  25. Kwan E, Carrai M, Lanave G, et al. Analysis of canine parvoviruses circulating in Australia reveals predominance of variant 2b and identifies feline parvovirus-like mutations in the capsid proteins. Transbound Emerg Dis 2021; 68(2): 656-666.
  26. Dinçer E. Molecular characterization and phylogenetic analysis of canine parvovirus 2 in Dogs, Mersin Province, Turkey. Etlik Vet Mikrobiyol Derg 2017; 28(2): 96-100.
  27. Battilani M, Ciulli S, Tisato E, et al. Genetic analysis of canine parvovirus isolates (CPV-2) from dogs in Italy. Virus Res 2002; 83(1-2): 149-157.
  28. Gallo Calderón M, Wilda M, Boado L, et al. Study of canine parvovirus evolution: comparative analysis of full-length VP2 gene sequences from Argentina and inter-national field strains. Virus Genes 2012; 44(1): 32-39.
  29. Truyen U. Evolution of canine parvovirus- -a need for new vaccines? Vet Microbiol 2006; 117(1): 9-13.
  30. Agbandje M, Parrish CR, Rossmann MG. The structure of parvoviruses. Semin Virol 1995; 6(5): 299-309.
  31. Hueffer K, Parrish CR. Parvovirus host range, cell tropism and evolution. Curr Opin Microbiol 2003; 6(4): 392-398.
  32. Pérez R, Bianchi P, Calleros L, et al. Recent spreading of a divergent canine parvovirus type 2a (CPV-2a) strain in a CPV-2c homogenous population. Vet Microbiol 2012; 155(2-4): 214-219.
  33. Xu J, Guo HC, Wei YQ, et al. Phylogenetic analysis of canine parvovirus isolates from Sichuan and Gansu provinces of China in 2011. Transbound Emerg Dis 2015; 62(1): 91-95.
  34. Jeoung SY, Ahn SJ, Kim D. Genetic analysis of VP2 gene canine parvovirus isolates in Korea. J Vet Med Sci 2008; 70(7): 719-722.
  35. Mukhopadhyay HK, Matta SL, Amsaveni S, et al. Phylogenetic analysis of canine parvovirus partial VP2 gene in India. Virus Genes 2014; 48(1): 89-95.
  36. Soma T, Taharaguchi S, Ohinata T, et al. Analysis of VP2 protein gene of canine parvovirus strains from affected dogs in Japan. Res Vet Sci 2013; 94(2): 368-371.
  37. Mittal M, Chakravarti S, Mohapatra JK, et al. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure. Infect Genet Evol 2014; 23: 1-6.
  38. Chen B, Zhang X, Zhu J, et al. Molecular epidemiological survey of canine parvovirus circulating in China from 2014 to 2019. Pathogens 2021; 10(5): 588. doi: 10.3390/pathogens10050588.
  39. Polat PF, Şahan A, Aksoy G, et al. Molecular and restriction fragment length polymorphism analysis of canine parvovirus 2 (CPV-2) in dogs in southeast Anatolia, Turkey. Onderstepoort J Vet Res 2019; 86(1): e1-e8. doi: 10.4102/ojvr.v86i1.1734.
  40. Kapil S, Cooper E, Lamm C, et al. Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007. J Clin Microbiol 2007; 45(12): 4044-4047.
  41. Decaro N, Cirone F, Desario C, et al. Severe parvovirus in a 12-year old dog that had been repeatedly vaccinated. Vet Rec 2009; 164(19): 593-595
  42. Decaro N, Desario C, Parisi A et al. Genetic analysis of canine parvovirus type 2c. Virology 2009; 385(1): 5-10.
  43. Decaro N, Desario C, Elia G, et al. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c. New Microbiol 2008; 31(1): 125-130.
  44. Decaro N, Buonavoglia C, Barrs VR. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication? Vet Microbiol 2020; 247:108760. doi: 10.1016/j.vetmic.2020.108760.
  45. Ghajari, M, Pourtaghi, H, Lotfi, M. Phylogenetic analysis of canine parvovirus 2 subtypes from diarrheic dogs in Iran. Iran J Vet Res 2021; 22(4): 347-351.
  46. Galvis CC, Jimenez-Villegas T, Reyes Romero DP, et al. Molecular diversity of the VP2 of Carnivore proto-parvovirus 1 (CPV-2) of fecal samples from Bogotá. J Vet Sci 2022; 23(1): e14. doi: 10.4142/jvs.21181.
  47. Burtonboy S, Charlier P, Hertoghs J, et al. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody. Vet Rec 1991; 128(16): 377-381.
  48. Martella V, Cavalli A, Decaro N, et al. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin Diagn Lab Immunol 2005; 12(10): 1243-1245.